Literature DB >> 8294904

Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors.

Z H Qin1, J F Chen, B Weiss.   

Abstract

To study the effects of altering dopaminergic input on the levels and rate of synthesis of dopamine receptors, corpora striata of mice were lesioned unilaterally with 6-hydroxydopamine (6-OHDA), and the densities and levels of the mRNAs for D1 and D2 dopamine receptors were determined. The results showed that 6-OHDA caused significant reductions in D1 dopamine receptors and in D1 dopamine receptor mRNA in dorsolateral and dorsomedial regions of the lesioned striatum. By contrast, 6-OHDA lesions caused significant increases in D2 dopamine receptors and in D2 dopamine receptor mRNA in dorsolateral and ventrolateral regions of the lesioned striatum. To assess the effects of 6-OHDA lesions on the rate of synthesis of D1 and D2 dopamine receptors, the irreversibly acting dopamine receptor antagonist 2-ethoxy-1-ethoxycarbonyl-1,2- dihydroquinoline (EEDQ) was administered, and the rate of recovery of these receptors determined. The lesions decreased the rate of synthesis of D1 dopamine receptors in dorsolateral striatum but increased the rate of synthesis of D2 dopamine receptors in dorsolateral striatum. Correlation of these molecular events with dopaminergic behaviors showed that the rate of recovery from EEDQ-induced cataleptic activity and the recovery from inhibition of quinpirole-induced rotational behavior was more rapid than the recovery of either the D1 or D2 dopamine receptor. These results suggest that dopaminergic denervation differentially affects the rate of synthesis of D1 and D2 dopamine receptors in mouse striatum, and that these alterations in the rates of synthesis of the receptors may be explained by corresponding alterations in the levels of the respective transcripts for these receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8294904     DOI: 10.1046/j.1471-4159.1994.62020411.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  Alteration of dopamine D2 receptors in human malignant stomach tissue.

Authors:  S Basu; P S Dasgupta
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats.

Authors:  G Cai; X Zhen; K Uryu; E Friedman
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

3.  Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.

Authors:  J H Cha; C M Kosinski; J A Kerner; S A Alsdorf; L Mangiarini; S W Davies; J B Penney; G P Bates; A B Young
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons.

Authors:  R D Todd; J Carl; S Harmon; K L O'Malley; J S Perlmutter
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

5.  Electroconvulsive shock increases dopamine D1 and D2 receptor mRNA in the nucleus accumbens of the rat.

Authors:  S Smith; N Lindefors; Y Hurd; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

6.  Supersensitive presynaptic dopamine D2 receptor inhibition of the striatopallidal projection in nigrostriatal dopamine-deficient mice.

Authors:  Wei Wei; Li Li; Guoliang Yu; Shengyuan Ding; Chengyao Li; Fu-Ming Zhou
Journal:  J Neurophysiol       Date:  2013-08-14       Impact factor: 2.714

7.  Reduced vocal variability in a zebra finch model of dopamine depletion: implications for Parkinson disease.

Authors:  Julie E Miller; George W Hafzalla; Zachary D Burkett; Cynthia M Fox; Stephanie A White
Journal:  Physiol Rep       Date:  2015-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.